UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 691

Sortiert nach

How liquid biopsies can change clinical practice in oncology

Annals of oncology, 2019-10, Vol.30 (10), p.1580-1590

2019

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers of angiogenesis and their role in the development of VEGF inhibitors

British journal of cancer, 2010-01, Vol.102 (1), p.8-18

2010

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial

Annals of oncology, 2019-07, Vol.30 (7), p.1114-1120

2019

Link zum Volltext

Verfügbarkeit prüfen

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker

British journal of cancer, 2012-01, Vol.106 (3), p.508-516

2012

Link zum Volltext

Verfügbarkeit prüfen

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer

European journal of cancer (1990), 2019-08, Vol.117, p.60-68

2019

Link zum Volltext

Verfügbarkeit prüfen

Consensus on precision medicine for metastatic cancers: a report from the MAP conference

Annals of oncology, 2016-08, Vol.27 (8), p.1443-1448

2016

Link zum Volltext

Verfügbarkeit prüfen

Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study

Annals of oncology, 2016-06, Vol.27 (6), p.1155-1160

2016

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance

Annals of oncology, 2015-01, Vol.26 (1), p.33-39

2015

Link zum Volltext

Verfügbarkeit prüfen

Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs

British journal of cancer, 2010-10, Vol.103 (9), p.1313-1317

2010

Link zum Volltext

Verfügbarkeit prüfen

Biomarker method validation in anticancer drug development

British journal of pharmacology, 2008-02, Vol.153 (4), p.646-656

2008

Link zum Volltext

Verfügbarkeit prüfen

iRFP (near-infrared fluorescent protein) imaging of subcutaneous and deep tissue tumours in mice highlights differences between imaging platforms

Cancer cell international, 2021-05, Vol.21 (1), p.247-247, Article 247

2021

Link zum Volltext

Verfügbarkeit prüfen

Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death

Oncogene, 2009-11, Vol.28 (45), p.4009-4021

2009

Link zum Volltext

Verfügbarkeit prüfen

Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA

Annals of oncology, 2016-10, Vol.27 (10), p.1959-1965

2016

Link zum Volltext

Verfügbarkeit prüfen

Cancer Moonshot Connecting International Liquid Biopsy Efforts Through Academic Partnership

Clinical pharmacology and therapeutics, 2017-05, Vol.101 (5), p.622-624

2017

Link zum Volltext

Verfügbarkeit prüfen

Report of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland

QJM : An International Journal of Medicine, 2018-12, Vol.111 (12), p.927-938

2018

Link zum Volltext

Verfügbarkeit prüfen

MS12.01 Circulating Biomarkers

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S179-S179

Dive, C.

2019

Link zum Volltext

Verfügbarkeit prüfen

Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial

Immuno-oncology technology, 2024-06, Vol.22, p.100712-100712, Article 100712

2024

Link zum Volltext

Verfügbarkeit prüfen

An open source R package for Droplet Digital PCR analysis

European journal of cancer (1990), 2016-07, Vol.61, p.S185-S185

2016

Link zum Volltext

Verfügbarkeit prüfen

PCAF is an HIF-1α cofactor that regulates p53 transcriptional activity in hypoxia

Oncogene, 2008-10, Vol.27 (44), p.5785-5796

2008

Link zum Volltext

Verfügbarkeit prüfen

Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death

Oncogene, 2009-11, Vol.28 (45), p.4009-4021

2009

Link zum Volltext

Verfügbarkeit prüfen

IAPs as a target for anticancer therapy

Current cancer drug targets, 2007-12, Vol.7 (8), p.785

2007

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling of tumour and ctDNA in a gastrointestinal cancer cohort at an academic cancer centre

Annals of oncology, 2018-09, Vol.29, p.vi23-vi24

2018

Link zum Volltext

Verfügbarkeit prüfen

Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trial

European journal of cancer (1990), 2019-08, Vol.117, p.48-59

2019

Link zum Volltext

Verfügbarkeit prüfen

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study

British journal of cancer, 2009-11, Vol.101 (10), p.1724-1730

2009

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib and randomised phase II trial of pazopanib with or without fosbretabulin in advanced recurrent ovarian cancer

Annals of oncology, 2018-10, Vol.29, p.viii342-viii342

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 691

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(626)
Mit Volltextzugriff
(565)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(322)
Life Sciences & Biomedicine
(295)
Humans
(270)
Biological And Medical Sciences
(146)
Female
(145)
Animals
(128)
Male
(125)
Medical Sciences
(108)
Middle Aged
(89)
Oncology
(84)
Adult
(80)
Aged
(67)
Mice
(65)
Biochemistry & Molecular Biology
(62)
Apoptosis
(58)
Tumors
(51)
Pharmacology. Drug Treatments
(43)
Cell Biology
(41)
Fundamental And Applied Biological Sciences. Psychology
(41)
Apoptosis - Drug Effects
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

How liquid biopsies can change clinical practice in oncology

Biomarkers of angiogenesis and their role in the development of VEGF inhibitors

Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer

Consensus on precision medicine for metastatic cancers: a report from the MAP conference

Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study

Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance

Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs

Biomarker method validation in anticancer drug development

iRFP (near-infrared fluorescent protein) imaging of subcutaneous and deep tissue tumours in mice highlights differences between imaging platforms

Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death

Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA

Cancer Moonshot Connecting International Liquid Biopsy Efforts Through Academic Partnership

Report of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland

MS12.01 Circulating Biomarkers

Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial

An open source R package for Droplet Digital PCR analysis

PCAF is an HIF-1α cofactor that regulates p53 transcriptional activity in hypoxia

Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death

IAPs as a target for anticancer therapy

Molecular profiling of tumour and ctDNA in a gastrointestinal cancer cohort at an academic cancer centre

Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trial

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study

A phase Ib and randomised phase II trial of pazopanib with or without fosbretabulin in advanced recurrent ovarian cancer

Suchergebnisse filtern